Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Wex, Thomas ^a   Kuester, Doerthe ^a   Schönberg, Cornelius ^a   Schindele, Daniel ^a   Treiber, Gerhard ^a,b   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Department of Gastroenterology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; GRN PROTEIN, HUMAN; MESSENGER RNA; SIGNAL PEPTIDE;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION; CELL LINE; CYTOLOGY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; STOMACH; STOMACH MUCOSA;

CELL LINE; EPITHELIAL CELLS; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RNA, MESSENGER; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; STOMACH; TRANSCRIPTION, GENETIC;

EID: 79957438858     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-63     Document Type: Article

References (30)

1. Sallenave JM. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Am J Respir Cell Mol Biol 2010, 42:635-643. 10.1165/rcmb.2010-0095RT, 20395631.
2. Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007, 23:370-378. 10.1097/MOG.0b013e328136c580, 17545771.
3. Weldon S, Taggart CC. Innate host defense functions of secretory leucoprotease inhibitor. Exp Lung Res 2007, 33:485-491. 10.1080/01902140701756547, 18075823.
4. Fitch PM, Roghanian A, Howie SE, Sallenave JM. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006, 34(Pt2):279-282.
5. Fink E, Nettelbeck R, Fritz H. Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. Biol.Chem.Hoppe Seyler 1986, 367:567-571. 10.1515/bchm3.1986.367.2.567, 3530282.
6. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. Antibacterial activity of antileukoprotease. Infect Immun 1996, 64:4520-4524. 174407, 8890201.
7. Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA. Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem 2002, 277:29999-30009. 10.1074/jbc.M203503200, 12023969.
8. Henriksen PA, Sallenave JM. Human neutrophil elastase: mediator and therapeutic target in atherosclerosis. Int J Biochem Cell Biol 2008, 40:1095-100. 10.1016/j.biocel.2008.01.004, 18289916.
9. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005, 202:1659-1668. 10.1084/jem.20050768, 2212970, 16352738.
10. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A. Conversion of proepithelin to epithelia's: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111:867-878. 10.1016/S0092-8674(02)01141-8, 12526812.
11. Samsom JN, van der Marel AP, van Berkel LA, van Helvoort JM, Simons-Oosterhuis Y, Jansen W, Greuter M, Nelissen RL, Meeuwisse CM, Nieuwenhuis EE, Mebius RE, Kraal G. Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance. J Immunol 2007, 179:6588-6595.
12. Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU, Ding A. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med 2000, 28:1276-1282. 10.1097/00003246-200005000-00003, 10834665.
13. Duits LA, Tjabringa GS, Aarts NJ, van't Wout JW, Hiemstra PS, Nibbering PH, van Dissel JT. Plasma secretory leukocyte protease inhibitor in febrile patients. Clin Microbiol Infect 2003, 9:605-613. 10.1046/j.1469-0691.2003.00582.x, 12925099.
14. Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis. Clin Exp Immunol 2003, 131:190-196. 10.1046/j.1365-2249.2003.02024.x, 1808594, 12519404.
15. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, Wu YC, Chen WJ, Yu CJ, Lin SR, Lin KH. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 2008, 123:1787-1796. 10.1002/ijc.23746, 18688858.
16. Sim SH, Liu Y, Wang D, Novem V, Sivalingam SP, Thong TW, Ooi EE, Tan G. Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection. PLoS One 2009, 4:e7308. 10.1371/journal.pone.0007308, 2751829, 19806192.
17. Weldon S, McNally P, McElvaney NG, Elborn JS, McAuley DF, Wartelle J, Belaaouaj A, Levine RL, Taggart CC. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol 2009, 183:8148-8156. 10.4049/jimmunol.0901716, 20007580.
18. Wex T, Treiber G, Nilius M, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect Immun 2004, 72:2383-2385. 10.1128/IAI.72.4.2383-2385.2004, 375164, 15039364.
19. Fakioglu E, Wilson SS, Mesquita PM, Hazrati E, Cheshenko N, Blaho JA, Herold BC. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J. Virol 2008, 82:9337-9344. 10.1128/JVI.00603-08, 2546954, 18667508.
20. Wex T, Ye S, Treiber G, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa. Helicobacter 2006, 11:31-38. 10.1111/j.0083-8703.2006.00376.x, 16423087.
21. Wex T, Treiber G, Venerito M, Leodolter A, Peitz U, Kuester D, Hritz I, Krueger S, Roessner A, Malfertheiner P. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases. Biol Chem 2006, 387:893-901. 10.1515/BC.2006.113, 16913839.
22. Bateman A, Bennett HP. Granulins: the structure and function of an emerging family of growth factors. J Endocrinol 1998, 158:145-151. 10.1677/joe.0.1580145, 9771457.
23. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003, 81:600-612. 10.1007/s00109-003-0474-3, 12928786.
24. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919. 10.1038/nature05016, 16862116.
25. Eriksen JL, Mackenzie IR. Progranulin: normal function and role in neurodegeneration. J Neurochem 2008, 4:287-297.
26. Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A, Belaaouaj A, Ring J, Ollert M, Fässler R, Jenne DE. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 2008, 118:2438-2447. 2430496, 18568075.
27. Kojima Y, Ono K, Inoue K, Takagi Y, Kikuta K, Nishimura M, Yoshida Y, Nakashima Y, Matsumae H, Furukawa Y, Mikuni N, Nobuyoshi M, Kimura T, Kita T, Tanaka M. Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis 2009, 206:102-108. 10.1016/j.atherosclerosis.2009.02.017, 19321167.
28. Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med 2011, 89:23-8. 10.1007/s00109-010-0677-3, 3016231, 20809089.
29. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, Beal MF, Nathan C, Ding A. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 2010, 207:117-128. 10.1084/jem.20091568, 2812536, 20026663.
30. Wex T, Kuester D, Vieth M, Treiber G, Krieg A, Roessner A, Malfertheiner P. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood. Scand J Gastroenterol 2008, 43:1194-1201. 10.1080/00365520802158598, 18609127.